Preview
Contents
A pharmacological approach to the treatment of arrhythmias BNF 2.3.1 - Antiarrhythmic drugsAdenosine BNF 2.3.2 - Flecainide BNF 2.3.2 - Cardiac glycosides (digitalis) BNF 2.1.1, 2.3.1, and 2.5.5 - Disopyramide BNF 2.3.2 - Amiodarone BNF 2.3.2 and 2.7.3 - Anticoagulants, antiplatelet drugs, and fibrinolytic drugsHeparins (unfractionated and low molecular weight) BNF 2.8.1 - Direct thrombin inhibitors BNF 2.8.2 - Fondaparinux sodium BNF 2.8.1 - Warfarin BNF 2.8.2 - Acetylsalicylic acid (aspirin) BNF 2.9 and 4.7.1 - Clopidogrel BNF 2.9 - Dipyridamole BNF 2.9 - Glycoprotein IIb/IIIa antagonists BNF 2.9 - Fibrinolytic drugs BNF 2.10.2 and 13.11.7 - Ischaemic heart diseasePharmacology of drugs used to treat acute coronary syndromes, including myocardial infarction BNF 2.10 - Pharmacology of drugs used to treat heart failure - Nitrate drugs BNF 2.6.1 - Nicorandil BNF 2.6.3 - Beta-adrenoceptor antagonists (‘beta-blockers’) BNF 2.4, 2.5.5, 6.2.2, 4.7.4, 11.6 - Angiotensin converting enzyme inhibitors (ACE inhibitors) BNF 2.5.5.1 - Angiotensin receptor antagonists/blockers (ARBs) BNF 2.5.5.2 - HypertensionAn approach to the treatment of hypertension BNF 2.5 - Methyldopa (alpha-methyldopa) BNF 2.5.2 - Calcium channel blockersCalcium channel blockers (see also individual sections) BNF 2.6.2 - Dihydropyridines (nifedipine-like) BNF 2.6.2 - Benzothiazepines (diltiazem) BNF 2.6.2 and 2.3.2 - Phenylalkylamines (verapamil) BNF 2.6.2 and 2.3.2 - Intravenous fluidsCrystalloid solutions for intravenous infusion BNF 9.2 - Colloid solutions for intravenous infusion BNF 9.2 - DiureticsSites of action of diuretics BNF 2.2 - Treatment of pulmonary oedema BNF - Loop diuretics BNF 2.2.2 and 2.2.4 - Thiazide and thiazide-like diuretics BNF 2.2.1, 2.5.5, and 6.5.2 - Potassium-sparing diuretics (amiloride and triamterene) BNF 2.2.3 and 2.2.4 - Spironolactone and eplerenone BNF 2.2.3, 2.2.4, and 2.5.5 - Adrenoceptor agonistsAdrenoceptor agonists (sympathomimetics) BNF 2.7 - Antimuscarinic drugsMuscarinic acetylcholine receptor antagonists (atropine and related compounds) BNF 15.1.3, 4.6, 4.9.2, 7.4.2, and 11.5 - Endothelin receptor antagonistsEndothelin receptor antagonists BNF 2.5.1 - Drugs for erectile dysfunctionPhosphodiesterase type V inhibitors BNF 7.4.5Also see Chapter 15
Chapter. 47402 words. Illustrated.
Subjects: clinical skills ; drugs and medicines ; cardiology
Go to Oxford Medicine Online » abstract
full text: subscription required